Molina Healthcare (MOH) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Molina Healthcare · Health Care · ref. ETF XLV · 106 calls · price $209.5
What the company does: Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States.
📈 Molina Healthcare (MOH) stock price
$209.5+7.5% over range
Oct 14, 25low $122.65 · high $242.88Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
0% recommend buying · 10 analysts
📊 JPI status : Molina Healthcare is no longer in our current JPI rankings, but appeared in the past (2016) — its upside may be behind it. See the stocks picked in 2016 →
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 MOH price target & analyst consensus — price $210
The price target · all analysts combined (10 targets)
Highest target · 1 firm of 10$230+9.8%
Median target · of 10 targets$205.5-1.9%
Lowest target · 1 firm of 10$163-22.2%
Current price$209.5
Where these 10 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
440%
$218 ↔ $230
Below
660%
$163 ↔ $209
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Truist Securities — 65% of its targets hit on this sector (110 calls tested). It aims for $225 (+7.4 %), call made on July 25, 2026, maturing on July 25, 2027 (81 d ago).
The 3 reliable analysts
$220+5.0 %
The 7 other firms
$191-8.8 %
How to read it: the 3 reliable firms are not filtered by optimism — 3 aim above the price, 0 below, hence their $220 median. “The 7 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 10 ratings (last 6 months)
Strong Buy00%
Buy00%
Hold990%
Sell110%
Strong Sell00%
Go deeper on the analysts
🎯 MOH price target all
All 106 calls, one by one, with our verdict on each firm.
→ See all 106 targets, analyst by analyst💡 The best analysts on MOH most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in MOH? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Molina Healthcare? The JPI assistant answers using our backtest data.
📈 Molina Healthcare fundamentals: valuation, margins & growth › open the full page
P/E 2327.8Net margin -0.0 %Revenue growth -5.7 %Very high P/E
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 2 %
2023
Rev +7%Profit +38%
2024
Rev +19%Profit +8%
2025
Rev +12%Profit −60%
🔎 Detailed analyses
🏛️ Which US Congress members hold Molina Healthcare (MOH)?
2 Congress members have disclosed MOH buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Daniel Goldman 1× · 25%Earl Blumenauer 1× · 38%
✅ Historical analyst reliability on MOH
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| SunTrust Robinson Humphrey | 100% | +52.5% | 3 |
| SVB Leerink | 100% | +48.3% | 4 |
| Deutsche Bank ↗ | 100% | +47.8% | 4 |
| Piper Sandler ↗ | 100% | +45.5% | 2 |
| Monness, Crespi, Hardt | 100% | +34.5% | 2 |
| Morgan Stanley ↗ | 75% | +29.3% | 24 |
| BMO Capital ↗ | 75% | +21.3% | 4 |
| Credit Suisse | 71% | +9.2% | 7 |
| B of A Securities ↗ | 69% | +6.7% | 13 |
| Goldman Sachs ↗ | 67% | +3.7% | 3 |
See the other 15 firms
| Stifel ↗ | 0% | -28.5% | 2 |
| Baird ↗ | 0% | -24.9% | 2 |
| Cantor Fitzgerald ↗ | 18% | -27.1% | 11 |
| TD Cowen ↗ | 25% | -23.6% | 4 |
| Wells Fargo ↗ | 36% | -10.5% | 14 |
| Truist Securities ↗ | 45% | -9.0% | 11 |
| Bernstein ↗ | 50% | -17.8% | 2 |
| Susquehanna ↗ | 50% | -7.4% | 2 |
| Wedbush ↗ | 50% | +0.2% | 2 |
| Leerink Swann | 50% | +3.6% | 4 |
| Citigroup ↗ | 50% | +6.2% | 2 |
| Barclays ↗ | 50% | +6.6% | 4 |
| JP Morgan ↗ | 55% | +23.8% | 11 |
| Mizuho ↗ | 56% | -0.4% | 9 |
| Jefferies ↗ | 64% | +8.9% | 11 |
📊 What $1,000 invested in Molina Healthcare would be worth › open the full page
In short — $1,000 invested in Molina Healthcare 10 years ago would be worth $4,017 today, i.e. +15%/yr on average. Best year: 2020 (+57%), worst: 2025 (-40%). Price performance, excluding dividends.
If I'd invested $1,000 in Molina Healthcare
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $830 | -17% |
| 3 years ago | $732 | -27% |
| 5 years ago | $1,136 | +14% |
Return by year (Molina Healthcare)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +39% | $1,392 (+39%) |
| 2025 | -40% | $830 (-17%) |
| 2024 | -19% | $669 (-33%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Molina Healthcare
Loading news…
📋 All analyst calls on MOH
Filtered on — · ✕ show all
Wells Fargo ↗
Jul 28, 26
■ Equal-Weight neutral · not a buy · 🎯$220
Price at call : $200.34 — gap to target +10%
Today : $209.5 — gap to target +5%
🎯 on MOH : 50% (2 calls matureds) · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
Truist Securities ↗
Jul 24, 26
■ Hold neutral · not a buy · 🎯$225
Price at call : $199.48 — gap to target +13%
Today : $209.5 — gap to target +7%
🎯 on MOH : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : Jul 24, 27
matures : Jul 24, 27
RBC Capital ↗
Jul 24, 26
■ Sector Perform neutral · not a buy · 🎯$218
Price at call : $199.48 — gap to target +9%
Today : $209.5 — gap to target +4%
🎯 on MOH : no call matured yet · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Jul 24, 27
matures : Jul 24, 27
▼ Underweight · 🎯$180
Price at call : $199.48 — upside -10%
Today : $209.5 — upside -14%
🎯 on MOH : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Jul 24, 27
matures : Jul 24, 27
■ Hold neutral · not a buy · 🎯$230
Price at call : $233.36 — gap to target -1%
Today : $209.5 — gap to target +10%
🎯 on MOH : no call matured yet · 📊 on Health : 55.6% · +19.8% (27 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
Truist Securities ↗
Jul 14, 26
■ Hold neutral · not a buy · 🎯$250
Price at call : $233.36 — gap to target +7%
Today : $209.5 — gap to target +19%
🎯 on MOH : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : Jul 14, 27
matures : Jul 14, 27
Wells Fargo ↗
Jul 13, 26
■ Equal-Weight neutral · not a buy · 🎯$235
Price at call : $241.56 — gap to target -3%
Today : $209.5 — gap to target +12%
🎯 on MOH : 50% (2 calls matureds) · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
RBC Capital ↗
Jul 9, 26
■ Sector Perform neutral · not a buy · 🎯$248
Price at call : $233.31 — gap to target +6%
Today : $209.5 — gap to target +18%
🎯 on MOH : no call matured yet · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
See the other 98 calls, newest to oldest
▼ Underweight · 🎯$184
Price at call : $233.31 — upside -21%
Today : $209.5 — upside -12%
🎯 on MOH : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
RBC Capital ↗
Jun 23, 26
■ Sector Perform neutral · not a buy · 🎯$216
Price at call : $201.42 — gap to target +7%
Today : $209.5 — gap to target +3%
🎯 on MOH : no call matured yet · 📊 on Health : 48.8% · +6.8% (201 calls)
in progress (365j)
matures : Jun 23, 27
matures : Jun 23, 27
■ Neutral neutral · not a buy · 🎯$191
Price at call : $203.06 — gap to target -6%
Today : $209.5 — gap to target -9%
🎯 on MOH : no call matured yet · 📊 on Health : 49% · +7.1% (147 calls)
in progress (365j)
matures : Jun 8, 27
matures : Jun 8, 27
Morgan Stanley ↗
Jun 4, 26
■ Equal-Weight neutral · not a buy · 🎯$167
Price at call : $190.86 — gap to target -13%
Today : $209.5 — gap to target -20%
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : Jun 4, 27
matures : Jun 4, 27
▼ Underweight · 🎯$199
Price at call : $177.87 — upside +12%
Today : $209.5 — upside -5%
🎯 on MOH : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : May 26, 27
matures : May 26, 27
■ Neutral neutral · not a buy · 🎯$202
Price at call : $176.2 — gap to target +15%
Today : $209.5 — gap to target -4%
🎯 on MOH : no call matured yet · 📊 on Health : 49.2% · +16.9% (124 calls)
in progress (365j)
matures : May 22, 27
matures : May 22, 27
Truist Securities ↗
May 11, 26
■ Hold neutral · not a buy · 🎯$205
Price at call : $191.58 — gap to target +7%
Today : $209.5 — gap to target -2%
🎯 on MOH : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : May 11, 27
matures : May 11, 27
Cantor Fitzgerald ↗
May 11, 26
■ Neutral neutral · not a buy · 🎯$209
Price at call : $185.19 — gap to target +13%
Today : $209.5 — gap to target -0%
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
in progress (365j)
matures : May 11, 27
matures : May 11, 27
■ Neutral neutral · not a buy · 🎯$163
Price at call : $185.19 — gap to target -12%
Today : $209.5 — gap to target -22%
🎯 on MOH : no call matured yet · 📊 on Health : 48.1% · +0.7% (77 calls)
in progress (365j)
matures : May 11, 27
matures : May 11, 27
Wells Fargo ↗
Apr 27, 26
■ Equal-Weight neutral · not a buy · 🎯$159
Price at call : $185.46 — gap to target -14%
Today : $209.5 — gap to target -24%
🎯 on MOH : 50% (2 calls matureds) · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Apr 27, 27
matures : Apr 27, 27
Truist Securities ↗
Apr 27, 26
■ Hold neutral · not a buy · 🎯$180
Price at call : $179.22 — gap to target +0%
Today : $209.5 — gap to target -14%
🎯 on MOH : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : Apr 27, 27
matures : Apr 27, 27
■ Neutral neutral · not a buy · 🎯$180
Price at call : $179.22 — gap to target +0%
Today : $209.5 — gap to target -14%
🎯 on MOH : no call matured yet · 📊 on Health : 49.2% · +16.9% (124 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
▼ Underweight · 🎯$161
Price at call : $179.22 — upside -10%
Today : $209.5 — upside -23%
🎯 on MOH : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
Morgan Stanley ↗
Apr 24, 26
■ Equal-Weight neutral · not a buy · 🎯$146
Price at call : $179.22 — gap to target -19%
Today : $209.5 — gap to target -30%
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
■ Neutral neutral · not a buy · 🎯$151
Price at call : $149.2 — gap to target +1%
Today : $209.5 — gap to target -28%
🎯 on MOH : no call matured yet · 📊 on Health : 49.2% · +16.9% (124 calls)
in progress (365j)
matures : Mar 12, 27
matures : Mar 12, 27
▲ Outperform · 🎯$180
Price at call : $149.19 — upside +21%
Today : $209.5 — upside -14%
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Mar 12, 27
matures : Mar 12, 27
Morgan Stanley ↗
Mar 4, 26
■ Equal-Weight neutral · not a buy · 🎯$128
Price at call : $147.71 — gap to target -13%
Today : $209.5 — gap to target -39%
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : Mar 4, 27
matures : Mar 4, 27
Wells Fargo ↗
Feb 20, 26
■ Equal-Weight neutral · not a buy · 🎯$141
Price at call : $151 — gap to target -7%
Today : $209.5 — gap to target -33%
🎯 on MOH : 50% (2 calls matureds) · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Feb 20, 27
matures : Feb 20, 27
Truist Securities ↗
Feb 17, 26
■ Hold neutral · not a buy · 🎯$145
Price at call : $142.61 — gap to target +2%
Today : $209.5 — gap to target -31%
🎯 on MOH : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : Feb 17, 27
matures : Feb 17, 27
Goldman Sachs ↗
Feb 12, 26
■ Neutral neutral · not a buy · 🎯$124
Price at call : $135.35 — gap to target -8%
Today : $209.5 — gap to target -41%
🎯 on MOH : no call matured yet · 📊 on Health : 59.5% · +16.1% (111 calls)
in progress (365j)
matures : Feb 12, 27
matures : Feb 12, 27
▼ Underweight · 🎯$133
Price at call : $122.65 — upside +8%
Today : $209.5 — upside -37%
🎯 on MOH : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
■ Hold neutral · not a buy · 🎯$144
Price at call : $125.43 — gap to target +15%
Today : $209.5 — gap to target -31%
🎯 on MOH : no call matured yet · 📊 on Health : 55.6% · +19.8% (27 calls)
in progress (365j)
matures : Feb 9, 27
matures : Feb 9, 27
Cantor Fitzgerald ↗
Feb 9, 26
■ Neutral neutral · not a buy · 🎯$144
Price at call : $127.53 — gap to target +13%
Today : $209.5 — gap to target -31%
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
in progress (365j)
matures : Feb 9, 27
matures : Feb 9, 27
Wells Fargo ↗
Jan 7, 26
▲ Overweight · 🎯$208
Price at call : $183.5 — upside +13%
Today : $209.5 — upside -1%
🎯 on MOH : 50% (2 calls matureds) · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Jan 7, 27
matures : Jan 7, 27
▼ Underweight · 🎯$164
Price at call : $182.8 — upside -10%
Today : $209.5 — upside -22%
🎯 on MOH : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
Wells Fargo ↗
Nov 12, 25
▲ Overweight · 🎯$165
Price at call : $138.48 — upside +19%
Today : $209.5 — upside -21%
🎯 on MOH : 50% (2 calls matureds) · 📊 on Health : 47.4% · +5.1% (152 calls)
in progress (365j)
matures : Nov 12, 26
matures : Nov 12, 26
Goldman Sachs ↗
Oct 24, 25
■ Neutral neutral · not a buy · 🎯$167
Price at call : $162.19 — gap to target +3%
Today : $209.5 — gap to target -20%
🎯 on MOH : no call matured yet · 📊 on Health : 59.5% · +16.1% (111 calls)
in progress (365j)
matures : Oct 24, 26
matures : Oct 24, 26
■ Neutral neutral · not a buy · 🎯$170
Price at call : $162.19 — gap to target +5%
Today : $209.5 — gap to target -19%
🎯 on MOH : no call matured yet · 📊 on Health : 49.2% · +16.9% (124 calls)
in progress (365j)
matures : Oct 24, 26
matures : Oct 24, 26
Cantor Fitzgerald ↗
Oct 24, 25
■ Neutral neutral · not a buy · 🎯$180
Price at call : $162.19 — gap to target +11%
Today : $209.5 — gap to target -14%
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
in progress (365j)
matures : Oct 24, 26
matures : Oct 24, 26
▼ Underweight · 🎯$144
Price at call : $163.32 — upside -12%
Today : $209.5 — upside -31%
🎯 on MOH : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Oct 24, 26
matures : Oct 24, 26
Morgan Stanley ↗
Oct 14, 25
■ Equal-Weight neutral · not a buy · 🎯$204
Price at call : $192.39 — gap to target +6%
Today : $209.5 — gap to target -3%
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 42% · -0.8% (200 calls)
in progress (365j)
matures : Oct 14, 26
matures : Oct 14, 26
Goldman Sachs ↗
Oct 14, 25
■ Neutral neutral · not a buy · 🎯$207
Price at call : $194.89 — gap to target +6%
Today : $209.5 — gap to target -1%
🎯 on MOH : no call matured yet · 📊 on Health : 59.5% · +16.1% (111 calls)
in progress (365j)
matures : Oct 14, 26
matures : Oct 14, 26
Wells Fargo ↗
Oct 7, 25
▲ Overweight · 🎯$231
Price at call : $202.92 — upside +14%
Today : $209.5 — upside +10%
Expected +14% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 50% (2 calls matureds) · 📊 on Health : 47.4% · +5.1% (152 calls)
-3.5%
stock -4% · XLV +16%
matured Oct 7, 26
▲ Outperform · 🎯$220
Price at call : $175.55 — upside +25%
Today : $209.5 — upside +5%
Expected +25% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 50% (2 calls matureds) · 📊 on Health : 42.9% · -5.6% (7 calls)
+11.8%
stock +12% · XLV +21%
matured Sep 5, 26
■ Equal-Weight neutral · not a buy · 🎯$185
Price at call : $174.65 — gap to target +6%
Today : $209.5 — gap to target -12%
🎯 on MOH : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Sep 4, 26
matures : Sep 4, 26
Cantor Fitzgerald ↗
Aug 26, 25
■ Neutral neutral · not a buy · 🎯$210
Price at call : $174.78 — gap to target +20%
Today : $209.5 — gap to target +0%
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
in progress (365j)
matures : Aug 26, 26
matures : Aug 26, 26
Wells Fargo ↗
Aug 15, 25
▲ Overweight · 🎯$198
Price at call : $167.49 — upside +18%
Today : $209.5 — upside -5%
Expected +18% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 50% (2 calls matureds) · 📊 on Health : 47.4% · +5.1% (152 calls)
+21.2%
stock +21% · XLV +23%
matured Aug 15, 26
■ Neutral neutral · not a buy · 🎯$184
Price at call : $159.97 — gap to target +15%
Today : $209.5 — gap to target -12%
🎯 on MOH : no call matured yet · 📊 on Health : 49% · +7.1% (147 calls)
in progress (365j)
matures : Jul 29, 26
matures : Jul 29, 26
■ Neutral neutral · not a buy · 🎯$180
Price at call : $164.19 — gap to target +10%
Today : $209.5 — gap to target -14%
🎯 on MOH : no call matured yet · 📊 on Health : 49.2% · +16.9% (124 calls)
in progress (365j)
matures : Jul 25, 26
matures : Jul 25, 26
Truist Securities ↗
Jul 25, 25
■ Hold neutral · not a buy · 🎯$180
Price at call : $164.19 — gap to target +10%
Today : $209.5 — gap to target -14%
🎯 on MOH : no call matured yet · 📊 on Health : 59.1% · +6.4% (110 calls)
in progress (365j)
matures : Jul 25, 26
matures : Jul 25, 26
■ Equal-Weight neutral · not a buy · 🎯$186
Price at call : $164.19 — gap to target +13%
Today : $209.5 — gap to target -11%
🎯 on MOH : no call matured yet · 📊 on Health : 48.3% · +1.1% (203 calls)
in progress (365j)
matures : Jul 25, 26
matures : Jul 25, 26
Cantor Fitzgerald ↗
Jul 25, 25
■ Neutral neutral · not a buy · 🎯$210
Price at call : $165.02 — gap to target +27%
Today : $209.5 — gap to target +0%
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
in progress (365j)
matures : Jul 25, 26
matures : Jul 25, 26
▲ Outperform · 🎯$330
Price at call : $218.95 — upside +51%
Today : $209.5 — upside +58%
Expected +51% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
+10.9%
stock +11% · XLV +20%
matured Jul 11, 26
Morgan Stanley ↗
Jun 9, 25
▲ Overweight · 🎯$364
Price at call : $295.69 — upside +23%
Today : $209.5 — upside +74%
Expected +23% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 42% · -0.8% (200 calls)
-33.1%
stock -33% · XLV +13%
matured Jun 9, 26
▲ Outperform · 🎯$414
Price at call : $332 — upside +25%
Today : $209.5 — upside +98%
Expected +25% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 50% (2 calls matureds) · 📊 on Health : 42.9% · -5.6% (7 calls)
-47.4%
stock -47% · XLV +8%
matured Apr 22, 26
▲ Outperform · 🎯$400
Price at call : $340.09 — upside +18%
Today : $209.5 — upside +91%
Expected +18% · Actual -57% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
-57.4%
stock -57% · XLV +8%
matured Apr 9, 26
▲ Outperform · 🎯$376
Price at call : $306.49 — upside +23%
Today : $209.5 — upside +79%
Expected +23% · Actual -51% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
-51.0%
stock -51% · XLV +6%
matured Mar 3, 26
Cantor Fitzgerald ↗
Oct 24, 24
▲ Overweight · 🎯$406
Price at call : $325.54 — upside +25%
Today : $209.5 — upside +94%
Expected +25% · Actual -50% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
-50.2%
stock -50% · XLV -1%
matured Oct 24, 25
Cantor Fitzgerald ↗
Oct 1, 24
▲ Overweight · 🎯$406
Price at call : $331.8 — upside +22%
Today : $209.5 — upside +94%
Expected +22% · Actual -41% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
-41.5%
stock -41% · XLV -6%
matured Oct 1, 25
Cantor Fitzgerald ↗
Sep 10, 24
▲ Overweight · 🎯$406
Price at call : $344.73 — upside +18%
Today : $209.5 — upside +94%
Expected +18% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
-45.3%
stock -45% · XLV -10%
matured Sep 10, 25
Cantor Fitzgerald ↗
Aug 19, 24
▲ Overweight · 🎯$406
Price at call : $348.5 — upside +16%
Today : $209.5 — upside +94%
Expected +16% · Actual -50% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
-50.2%
stock -50% · XLV -11%
matured Aug 19, 25
Cantor Fitzgerald ↗
Jul 25, 24
▲ Overweight · 🎯$406
Price at call : $335.36 — upside +21%
Today : $209.5 — upside +94%
Expected +21% · Actual -51% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
-51.0%
stock -51% · XLV -10%
matured Jul 25, 25
Cantor Fitzgerald ↗
Jul 23, 24
▲ Overweight · 🎯$406
Price at call : $288.72 — upside +41%
Today : $209.5 — upside +94%
Expected +41% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
-45.2%
stock -45% · XLV -9%
matured Jul 23, 25
Cantor Fitzgerald ↗
Apr 4, 24
▲ Overweight · 🎯$406
Price at call : $376.77 — upside +8%
Today : $209.5 — upside +94%
Expected +8% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
-9.7%
stock -10% · XLV -6%
matured Apr 4, 25
B of A Securities ↗
Apr 1, 24
▼ Underperform · 🎯$439
Price at call : $404.2 — upside +9%
Today : $209.5 — upside +110%
Expected +9% · Actual -19% · Reason (≤ −15%) : ✓ Yes
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+18.9%
stock -19% · XLV -2%
matured Apr 1, 25
B of A Securities ↗
Mar 28, 24
▼ Underperform · 🎯$439
Price at call : $410.83 — upside +7%
Today : $209.5 — upside +110%
Expected +7% · Actual -21% · Reason (≤ −15%) : ✓ Yes
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+21.4%
stock -21% · XLV -2%
matured Mar 28, 25
Cantor Fitzgerald ↗
Feb 9, 24
▲ Overweight · 🎯$406
Price at call : $392.63 — upside +3%
Today : $209.5 — upside +94%
Expected +3% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
-27.1%
stock -27% · XLV +1%
matured Feb 8, 25
Cantor Fitzgerald ↗
Nov 21, 23
▲ Overweight · 🎯$374
Price at call : $364.87 — upside +3%
Today : $209.5 — upside +79%
Expected +3% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
-18.9%
stock -19% · XLV +10%
matured Nov 20, 24
Cantor Fitzgerald ↗
Sep 14, 23
▲ Overweight · 🎯$359
Price at call : $327.6 — upside +10%
Today : $209.5 — upside +71%
Expected +10% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+10.1%
stock +10% · XLV +19%
matured Sep 13, 24
Morgan Stanley ↗
Jul 14, 23
▲ Overweight · 🎯$365
Price at call : $299.91 — upside +22%
Today : $209.5 — upside +74%
Expected +22% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 42% · -0.8% (200 calls)
-5.3%
stock -5% · XLV +13%
matured Jul 13, 24
Cantor Fitzgerald ↗
Apr 21, 23
▲ Overweight · 🎯$354
Price at call : $275.54 — upside +28%
Today : $209.5 — upside +69%
Expected +28% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 18% (11 calls matureds) · 📊 on Health : 56.4% · +17.2% (117 calls)
+31.3%
stock +31% · XLV +4%
matured Apr 20, 24
▲ Buy · 🎯$366
Price at call : $327.72 — upside +12%
Today : $209.5 — upside +75%
Expected +12% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
-7.1%
stock -7% · XLV +1%
matured Jul 29, 23
B of A Securities ↗
May 26, 22
▼ Underperform · 🎯$335
Price at call : $299.02 — upside +12%
Today : $209.5 — upside +60%
Expected +12% · Actual -9% · Reason (≤ −15%) : ✗ No
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+8.7%
stock -9% · XLV -3%
matured May 26, 23
Morgan Stanley ↗
Feb 22, 22
▲ Overweight · 🎯$365
Price at call : $307.68 — upside +19%
Today : $209.5 — upside +74%
Expected +19% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 42% · -0.8% (200 calls)
-4.4%
stock -4% · XLV +2%
matured Feb 22, 23
▲ Buy · 🎯$345
Price at call : $303.23 — upside +14%
Today : $209.5 — upside +65%
Expected +14% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
-1.3%
stock -1% · XLV +3%
matured Feb 11, 23
Morgan Stanley ↗
Oct 29, 21
▲ Overweight · 🎯$397
Price at call : $297.97 — upside +33%
Today : $209.5 — upside +89%
Expected +33% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 42% · -0.8% (200 calls)
+20.4%
stock +20% · XLV -1%
matured Oct 29, 22
Morgan Stanley ↗
Sep 20, 21
▲ Overweight · 🎯$316
Price at call : $277.39 — upside +14%
Today : $209.5 — upside +51%
Expected +14% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 42% · -0.8% (200 calls)
+21.8%
stock +22% · XLV -5%
matured Sep 20, 22
▲ Buy · 🎯$305
Price at call : $277.39 — upside +10%
Today : $209.5 — upside +46%
Expected +10% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
+21.8%
stock +22% · XLV -5%
matured Sep 20, 22
Morgan Stanley ↗
Aug 31, 21
▲ Overweight · 🎯$296
Price at call : $268.77 — upside +10%
Today : $209.5 — upside +41%
Expected +10% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 42% · -0.8% (200 calls)
+25.5%
stock +26% · XLV -8%
matured Aug 31, 22
▲ Buy · 🎯$284
Price at call : $273.01 — upside +4%
Today : $209.5 — upside +36%
Expected +4% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
+19.0%
stock +19% · XLV -1%
matured Jul 30, 22
Morgan Stanley ↗
Jun 3, 21
▲ Overweight · 🎯$297
Price at call : $249 — upside +19%
Today : $209.5 — upside +42%
Expected +19% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 42% · -0.8% (200 calls)
+15.1%
stock +15% · XLV +6%
matured Jun 3, 22
▲ Buy · 🎯$273
Price at call : $256.23 — upside +7%
Today : $209.5 — upside +30%
Expected +7% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
+19.6%
stock +20% · XLV +6%
matured Apr 30, 22
▲ Buy · 🎯$245
Price at call : $223.47 — upside +10%
Today : $209.5 — upside +17%
Expected +10% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 56% (9 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
+41.5%
stock +42% · XLV +14%
matured Mar 10, 22
Morgan Stanley ↗
May 15, 20
▲ Overweight · 🎯$229
Price at call : $181.42 — upside +26%
Today : $209.5 — upside +9%
Expected +26% · Actual +44% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 42% · -0.8% (200 calls)
+44.4%
stock +44% · XLV +23%
matured May 15, 21
Morgan Stanley ↗
Apr 13, 20
▲ Overweight · 🎯$175
Price at call : $163.29 — upside +7%
Today : $209.5 — upside -16%
Expected +7% · Actual +50% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 42% · -0.8% (200 calls)
+49.5%
stock +50% · XLV +22%
matured Apr 13, 21
B of A Securities ↗
Apr 8, 20
▲ Buy
Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+57.2%
stock +57% · XLV +24%
matured Apr 8, 21
Morgan Stanley ↗
Mar 27, 20
▲ Overweight · 🎯$165
Price at call : $139.35 — upside +18%
Today : $209.5 — upside -21%
Expected +18% · Actual +67% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 42% · -0.8% (200 calls)
+67.4%
stock +67% · XLV +32%
matured Mar 27, 21
Morgan Stanley ↗
Oct 31, 19
▲ Overweight · 🎯$158
Price at call : $117.64 — upside +34%
Today : $209.5 — upside -25%
Expected +34% · Actual +59% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 42% · -0.8% (200 calls)
+58.5%
stock +59% · XLV +7%
matured Oct 30, 20
Morgan Stanley ↗
Aug 23, 19
▲ Overweight · 🎯$172
Price at call : $127.33 — upside +35%
Today : $209.5 — upside -18%
Expected +35% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 75% (12 calls matureds) · 📊 on Health : 42% · -0.8% (200 calls)
+42.6%
stock +43% · XLV +20%
matured Aug 22, 20
▲ Buy · 🎯$169
Price at call : $135.36 — upside +25%
Today : $209.5 — upside -19%
Expected +25% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 48.3% · +10.7% (116 calls)
-10.2%
stock -10% · XLV +5%
matured Nov 13, 19
B of A Securities ↗
Aug 1, 18
▼ Underperform · 🎯$110
Price at call : $128.35 — upside -14%
Today : $209.5 — upside -47%
Expected -14% · Actual +1% · Reason (≤ −15%) : ✗ No
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
-0.7%
stock +1% · XLV +2%
matured Aug 1, 19
B of A Securities ↗
Jul 24, 18
▼ Underperform · 🎯$94
Price at call : $106.38 — upside -12%
Today : $209.5 — upside -55%
Expected -12% · Actual +27% · Reason (≤ −15%) : ✗ No
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
-27.4%
stock +27% · XLV +3%
matured Jul 24, 19
▲ Buy
Actual +45% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 48.3% · +10.7% (116 calls)
+45.2%
stock +45% · XLV +10%
matured Jun 22, 19
B of A Securities ↗
Jul 14, 17
▼ Underperform · 🎯$60
Price at call : $70.26 — upside -15%
Today : $209.5 — upside -71%
Expected -15% · Actual +51% · Reason (≤ −15%) : ✗ No
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
-50.8%
stock +51% · XLV +9%
matured Jul 14, 18
▲ Buy · 🎯$70
Price at call : $54.81 — upside +28%
Today : $209.5 — upside -67%
Expected +28% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 48.3% · +10.7% (116 calls)
+20.5%
stock +21% · XLV +16%
matured Sep 13, 17
▲ Buy · 🎯$63
Price at call : $56.81 — upside +11%
Today : $209.5 — upside -70%
Expected +11% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 48.3% · +10.7% (116 calls)
+17.6%
stock +18% · XLV +6%
matured Jul 28, 17
B of A Securities ↗
Apr 29, 16
▼ Underperform
Actual -2% · Reason (≤ −15%) : ✗ No
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+1.8%
stock -2% · XLV +8%
matured Apr 29, 17
▲ Buy · 🎯$73
Price at call : $55.93 — upside +31%
Today : $209.5 — upside -65%
Expected +31% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 48.3% · +10.7% (116 calls)
+1.5%
stock +2% · XLV +6%
matured Jan 7, 17
▲ Buy · 🎯$84
Price at call : $72.71 — upside +16%
Today : $209.5 — upside -60%
Expected +16% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 48.3% · +10.7% (116 calls)
-28.5%
stock -28% · XLV -4%
matured Jul 14, 16
▲ Buy · 🎯$80
Price at call : $65.12 — upside +23%
Today : $209.5 — upside -62%
Expected +23% · Actual -28% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 48.3% · +10.7% (116 calls)
-27.6%
stock -28% · XLV -5%
matured May 7, 16
B of A Securities ↗
Nov 18, 14
▲ Buy · 🎯$57
Price at call : $50.77 — upside +12%
Today : $209.5 — upside -73%
Expected +12% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+24.9%
stock +25% · XLV +5%
matured Nov 18, 15
▲ Buy · 🎯$50
Price at call : $41.7 — upside +20%
Today : $209.5 — upside -76%
Expected +20% · Actual +84% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 48.3% · +10.7% (116 calls)
+83.7%
stock +84% · XLV +25%
matured Aug 2, 15
▲ Buy · 🎯$54
Price at call : $45.54 — upside +19%
Today : $209.5 — upside -74%
Expected +19% · Actual +53% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 48.3% · +10.7% (116 calls)
+53.2%
stock +53% · XLV +23%
matured Jul 11, 15
B of A Securities ↗
May 2, 14
▲ Buy · 🎯$44
Price at call : $39.08 — upside +13%
Today : $209.5 — upside -79%
Expected +13% · Actual +53% · Reason (≥ +15%) : ✓ Yes
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+53.0%
stock +53% · XLV +27%
matured May 2, 15
▲ Buy · 🎯$47
Price at call : $39.13 — upside +20%
Today : $209.5 — upside -78%
Expected +20% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 64% (11 calls matureds) · 📊 on Health : 48.3% · +10.7% (116 calls)
+14.0%
stock +14% · XLV +25%
matured Sep 16, 14
B of A Securities ↗
Feb 13, 13
▲ Buy · 🎯$41
Price at call : $32.99 — upside +24%
Today : $209.5 — upside -80%
Expected +24% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
+7.2%
stock +7% · XLV +34%
matured Feb 13, 14
B of A Securities ↗
Oct 24, 12
▼ Underperform · 🎯$23
Price at call : $25.82 — upside -11%
Today : $209.5 — upside -89%
Expected -11% · Actual +34% · Reason (≤ −15%) : ✗ No
🎯 on MOH : 67% (12 calls matureds) · 📊 on Health : 64.2% · +20.2% (109 calls)
-34.4%
stock +34% · XLV +30%
matured Oct 24, 13
Frequently asked questions
Should I buy Molina Healthcare stock?
This isn't buy advice. For Molina Healthcare, the analyst consensus is "Hold", with an average price target of $206 (-2% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on Molina Healthcare). We show the numbers — you decide.
Is it too late to buy Molina Healthcare? How high can it go?
The most bullish analyst target on Molina Healthcare is $230 (+10% above today's price); the average is $206. That's the upside they see. Check how reliable those analysts have actually been on Molina Healthcare on our site before trusting it.
Is Molina Healthcare still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 25 analysts have a real record on Molina Healthcare, the best hitting 100% over 3 calls. Current consensus: "Hold". Make your call on data, not noise.
Should you invest in Molina Healthcare? The case for and against
The arguments for and against, one by one, from the numbers: why invest in MOH (and why hesitate).
What has Molina Healthcare's past performance been?
Historical returns and a "how much if I had invested" calculator: MOH performance & returns.
What is the best month to buy MOH?
The 12 months ranked by the stock's past returns: best & worst month to buy MOH.
Are insiders buying MOH stock?
Executives' and large holders' buys and sells, decoded: insider buying on MOH.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX